Joseph Kessler

Optimization and Validation of a Multiplexed Luminex Assay To Quantify Antibodies to Neutralizing Epitopes on Human Papillomaviruses 6, 11, 16, and 18

Dennis Dias, Jeff Van Doren, Sonela A. Schlottmann et al. · Clinical and Vaccine Immunology · 2005 · 243 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D

Alan J. Conley, Miroslaw K. Górny, Joseph Kessler et al. · Journal of Virology · 1994 · 213 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +13

Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody.

Alan J. Conley, Joseph Kessler, L J Boots et al. · Proceedings of the National Academy of Sciences · 1994 · 212 citations

Life Sciences, Immunology, Infectious Diseases +12

Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees

Emilio A. Emini, Peter L. Nara, William A. Schleif et al. · Journal of Virology · 1990 · 153 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties

Dooseop Kim, Liping Wang, Jeffrey J. Hale et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 149 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16